eClinical Technology and Industy News

Karyopharm’s Founder, Sharon Shacham, PhD, Selected as a Finalist for the EY Entrepreneur Of The Year® 2020 Award

Excerpt from the Press Release:

NEWTON, Mass., Aug. 21, 2020 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, congratulates its founder, President and Chief Scientific Officer, Sharon Shacham, PhD, MBA, for being selected as a finalist in the EY Entrepreneur of the Year 2020 New England Awards Program. For more than 30 years, this award has served as one of the world’s most prestigious business awards recognizing entrepreneurs who have disrupted industries, created new product categories and successfully brought innovations that have transformed our world. Dr. Shacham was recognized for her scientific research that led to the development and FDA approval of XPOVIO® (selinexor), as well as for leading Karyopharm from its inception to what is now a global pharmaceutical company focused on the discovery, development, and commercialization of novel medicines for patients with cancer and other major diseases.

“Not only is Dr. Shacham a renowned expert in the biologic mechanisms of cancer and a pioneer in advancing important medical innovations, but she is a true business leader who inspires those around her to achieve extraordinary results,” said Michael G. Kauffman, MD, PhD, Chief Executive Officer of Karyopharm. “Under her scientific leadership, we have built a robust research and development organization since our founding in 2008 and have the only nuclear export inhibitor approved in the U.S. This award recognizes the importance of her entrepreneurial spirit and the vital role her leadership and persistence have played in bringing new treatment options to patients battling cancer and other serious diseases.”

Click the button below to read the Press Release:

Continue Reading The Press Release

Request Your Demo Today!

From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?

Archives